Home/Filings/4/0001543077-16-000008
4//SEC Filing

ARGOS THERAPEUTICS INC 4

Accession 0001543077-16-000008

CIK 0001105533operating

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 4:31 PM ET

Size

7.5 KB

Accession

0001543077-16-000008

Insider Transaction Report

Form 4
Period: 2016-06-13
Abbey Jeffrey D
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2016-06-13+250,000250,000 total
    Exercise: $7.41Exp: 2026-06-12Common Stock (250,000 underlying)
  • Award

    Common Stock

    2016-06-13+10,924109,620 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units vest in twelve equal monthly installments beginning June 30, 2016. Vested shares will be delivered to the reporting person on each vesting date.
  • [F2]Includes 2,002 shares of common stock acquired pursuant to the 2014 Employee Stock Purchase Plan on March 10, 2016.
  • [F3]This option was granted on June 13, 2016 and vests as to 25% of the shares underlying this option on June 13, 2017, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning June 13, 2017.

Issuer

ARGOS THERAPEUTICS INC

CIK 0001105533

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001105533

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:31 PM ET
Size
7.5 KB